Pharma’s digital health ambitions: Where are the opportunities and what’s hindering progress?
Looking to the future, Michael Doherty, head of strategic innovation for pharma development at Roche, said: "We are heading to a new model of drug development that will be more flexible, data will be much more continual and contextual...It won't be dated."